Thomas Bauer, MD, is Chief of Thoracic
Surgery at the Helen F. Graham Cancer Center, Christiana Care
Health System, in Newark, Delaware, and Principal Investigator
of the Biomoda Phase II clinical trial currently underway.
He is also a clinical assistant professor of surgery at
Jefferson Medical College and adjunct assistant professor of
biological sciences at the University of Delaware. He has
lead several lung and esophageal cancer studies and heads up
Christiana’s participation in the International Early Lung
Cancer Action Program (I-ELCAP). Dr. Bauer has authored
dozens of peer- and nonpeer-reviewed publications and abstracts
and serves on many committees and programs.
Dan Merrick, MD, is known for his work
in anatomic and clinical pathology, and molecular genetic
pathology. He has published several papers on lung cancer
and is an expert on sputum cytology. Dr. Merrick graduated
from the University of Washington Medical School.
Tim Kennedy, MD, is associated with the
University of Colorado and specializes in internal medicine,
pulmonology and cytopathology. He is an expert in sputum
cytology. Dr. Kennedy has authored many peer-reviewed
publications, belongs to dozens of professional societies and
serves on many committees. He has held faculty positions
at the University of Arizona and University of Colorado Health
Sciences Center.
Ramesh Gopal, MD, is a board-certified
radiation oncologist serving as Medical Director of radiation
treatment at the M.D. Anderson Cancer Center satellite at the
Presbyterian Kaseman Hospital in Albuquerque, New Mexico.
Lara Patriquin, MD, is a Principal
Investigator for Biomoda’s Phase II clinical trial. Dr.
Patriquin is a radiologist at Radiology Associates and
Presbyterian Hospital in Albuquerque, New Mexico.
Steve Groshong, MD, PhD, is a
pathologist at the National Jewish Hospital in Denver and
Assistant Professor at the University of Colorado, Denver.
|
|
Richard Phillips MSPH,
PhD is a Principal Consultant in Medical Device development at
Quintiles Consulting. He had four years of employment at
FDA’s Office of Device Evaluation, serving as a first-line
scientific reviewer in the Chemistry and Toxicology Branch,
Division of Clinical Laboratory Devices, and then as Chief,
Anesthesiology and Defibrillator Devices Branch, Division of
Cardiovascular, Respiratory and Neurological Devices.
Before joining FDA, Dr. Phillips worked for three in vitro
diagnostic device companies, serving each company in the
capacity of Director of Clinical Research/Clinical Affairs. Dr.
Phillips is a Diplomate of the American Board of Forensic
Toxicology, and the author of numerous papers in clinical
chemistry, analytical and forensic toxicology, and in vitro
diagnostic devices. He is a member of the American
Association for Clinical Chemistry, Association of Clinical
Scientists, Clinical Ligand Assay Society, Society of Forensic
Toxicologists, and the American Academy of Forensic Sciences.
Dr. Phillips earned his BS in Biology and Chemistry from Marian
University, Indianapolis, IN, his MSPH from Univ. of North
Carolina, Chapel Hill, NC, and his Ph.D. from Indiana
University, Bloomington, IN.
Richard Holcomb PhD
is an Associate Senior Consultant with Quintiles. Dr.
Holcomb works with clients in the medical device,
pharmaceutical, biologic, and biotechnology industries to
develop and implement preclinical and clinical development
plans, with special emphasis in medical devices regulated by the
Food and Drug Administration (FDA). Dr. Holcomb has a B.S.
in Mathematics from Michigan Technological University, an M.S.
and a Ph.D. in Biometry from the University of Minnesota.
Tom Zimmerman, CRO
Project Advisor with Alquest, Inc., has 25 years experience in
clinical laboratory operations and management. He is an expert
in laboratory logistics, data management, point-of-care issues,
quality assurance and validation. Mr. Zimmerman has worked for
Nichols Institute Reference Laboratories, SmithKline Beecham
Clinical Laboratories, Focus Diagnostics, Medtox Laboratories,
ViroMed Laboratories, and Mayo Medical Laboratories/Clinical
Trial Services where he was senior analyst programmer and more
recently Operations Administrator for Core Laboratory Services.
Tom earned his BA from St Cloud State University in Minnesota
|